Maternal breastfeeding history and alzheimer's disease risk

Journal of Alzheimer's Disease

Volumn 37, Issue 4, 2013, Pages 809-821

  Fox, Molly ^a   Berzuini, Carlo ^b   Knapp, Leslie A ^a,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

Alzheimer's disease; breastfeeding; estrogen; hormones; lactation; reproductive history; risk factors

Indexed keywords

HORMONE;

AGED; ALZHEIMER DISEASE; ARTICLE; BREAST FEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN SENSITIVITY; INTERVIEW; MEDICAL HISTORY; PRIORITY JOURNAL; RISK REDUCTION;

ALZHEIMER'S DISEASE; BREASTFEEDING; ESTROGEN; HORMONES; LACTATION; REPRODUCTIVE HISTORY; RISK FACTORS;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BREAST FEEDING; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; MATERNAL BEHAVIOR; RISK FACTORS;

EID: 84888298543     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-130152     Document Type: Article

References (81)

1. Phipps AI, Malone KE, Porter PL, Daling JR, Li CI (2008) Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer. Cancer 113, 1521-1526.
2. Newcomb PA, Storer BE, Longnecker MP, Mittendorf R, Greenberg ER, Clapp RW, Burke KP, Willett WC, MacMahon B (1994) Lactation and a reduced risk of premenopausal breast cancer. N Engl J Med 330, 81-87.
3. Chang-Claude J, Eby N, Kiechle M, Bastert G, Becher H (2000) Breastfeeding and breast cancer risk by age 50 among women in Germany. Cancer Causes Control 11, 687-695.
4. Yang L, Jacobsen KH (2008) A systematic review of the association between breastfeeding and breast cancer. J Womens Health 17, 1635-1645.
5. Lipworth L, Bailey LR, Trichopoulos D (2000) History of breast-feeding in relation to breast cancer risk: A review of the epidemiologic literature. J Natl Cancer Inst 92, 302-312.
6. Kreiger N,Kelsey JL, Holford TR, O'ConnorT(1982)Anepidemiologic study of hip fracture in postmenopausal women. Am J Epidemiol 116, 141-148.
7. Grimes JP, Wimalawansa SJ (2003) Breastfeeding and postmenopausal osteoporosis. Curr Womens Health Rep 3, 193-198.
8. Kane S, Lemieux N (2005) The role of breastfeeding in postpartum disease activity in women with inflammatory bowel disease. Am J Gastroenterol 100, 102-105.
9. Barrett JH, Brennan P, Fiddler M, Silman A (2000) Breastfeeding and postpartum relapse in women with rheumatoid and inflammatory arthritis. Arthritis Rheum 43, 1010-1015.
10. Langer-Gould A, Huang SM, Gupta R, Leimpeter AD, Greenwood E, Albers KB, Van Den Eeden SK, Nelson LM (2009) Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis. Arch Neurol 66, 958-963.
11. Hellwig K, Haghikia A, Agne H, Beste C, Gold R (2009) Protective effect of breastfeeding in postpartum relapse rate of mothers with multiple sclerosis. Arch Neurol 66, 1580-1581.
12. Rasgon NL, Magnusson C, Johansson ALV, Pedersen NL, Elman S, GatzM(2005) Endogenous and exogenous hormone exposure and risk of cognitive impairment in Swedish twins: Apreliminary study. Psychoneuroendocrinology 30, 558-567.
13. Ryan J, Carriere I, Scali J, Ritchie K, AncelinML(2009) Lifetime estrogen exposure and cognitive functioning in later life. Psychoneuroendocrinology 34, 287-298.
14. Kim J, Stewart R, Shin I, Yoon J (2003) Limb length and dementia in an older Korean population. J Neurol Neurosurg Psychiatry 74, 427-432.
15. Hong X, Zhang X, Li H (2001) A case-control study of endogenous estrogen and risk of Alzheimer's disease. Zhonghua Liu Xing Bing Xue Za Zhi 22, 379-382.
16. Paganini-Hill A, Henderson VW (1994) Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 140, 256-261.
17. Lebrun CEI, Van Der Schouw YT, De Jong FH, Pols HAP, Grobbee DE, Lamberts SWJ (2005) Endogenous oestrogens are related to cognition in healthy elderly women. Clin Endocrinol (Oxf) 63, 50-55.
18. McLay RN, Maki PM, Lyketsos CG (2003) Nulliparity and late menopause are associated with decreased cognitive decline. J Neuropsychiatr Clin Neurosci 15, 161-167.
19. Schupf N, Pang D, Patel BN, SilvermanW, Schubert R, Lai F, Kline JK, SternY, Ferin M, TyckoB(2003) Onset of dementia is associated with age at menopause in women with Down's syndrome. Ann Neurol 54, 433-438.
20. Cosgrave M, Tyrrell J, McCarron M, Gill M, Lawlor B (1999) Age at onset of dementia and age of menopause in women with Down's syndrome. J Intellect Disabil Res 43, 461-465.
21. Heys M, Jiang C, Cheng KK, Zhang W, Yeung SLA, Lam TH, Leung GM, Schooling CM (2011) Life long endogenous estrogen exposure and later adulthood cognitive function in a population of naturally postmenopausal women from Southern China: The Guangzhou Biobank Cohort Study. Psychoneuroendocrinology 36, 864-873.
22. Henderson V, Guthrie J, Dudley E, Burger H, Dennerstein L (2003) Estrogen exposures and memory at midlife: A population-based study of women. Neurology 60, 1369-1371.
23. Colucci M, Cammarata S, Assini A, Croce R, Clerici F, Novello C, Mazzella L, Dagnino N, Mariani C, Tanganelli P (2006) The number of pregnancies is a risk factor for Alzheimer's disease. Eur J Neurol 13, 1374-1377.
24. Low LF, Anstey K, Jorm A, Rodgers B, Christensen H (2005) Reproductive period and cognitive function in a representative sample of naturally postmenopausalwomen aged 60-64 years. Climacteric 8, 380-389.
25. Geerlings MI, RuitenbergA,Witteman JCM, van Swieten JC, Hofman A, van Duijn CM, Breteler MMB, Launer LJ (2001) Reproductive period and risk of dementia in postmenopausal women. JAMA 285, 1475-1481.
26. Ptok U, Barkow K, Heun R (2002) Fertility and number of children in patients with Alzheimer's disease. Arch Womens Ment Health 5, 83-86.
27. Beeri MS, Rapp M, Schmeidler J, Reichenberg A, Purohit DP, Perl DP, Grossman HT, Prohovnik I, Haroutunian V, Silverman JM (2009) Number of children is associated with neuropathology of Alzheimer's disease in women. Neurobiol Aging 30, 1184-1191.
28. Corbo RM, Gambina G, Ulizzi L, Monini P, Broggio E, Rosano A, Scacchi R (2007) Combined effect of apolipoprotein e genotype and past fertility on age at onset of Alzheimer's disease in women. Dement Geriatr Cogn Disord 24, 82-85.
29. Shumaker SA, Reboussin BA, Espeland MA, Rapp SR, McBee WL, Dailey M, Bowen D, Terrell T, Jones BN (1998) The Women's Health Initiative Memory Study (WHIMS): A trial of the effect of estrogen therapy in preventing and slowing the progression of dementia. Control Clin Trials 19, 604-621.
30. Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE (2004) Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women. JAMA 291, 2947-2958.
31. LeBlanc ES, Janowsky J, Chan BK, Nelson HD (2001) Hormone replacement therapy and cognition. JAMA 285, 1489-1499.
32. Whitmer RA, QuesenberryCP, Zhou J,YaffeK(2011)Timing of hormone therapy and dementia: The critical windowtheory revisited. Ann Neurol 69, 163-169.
33. Zandi PP, Carlson MC, Plassman BL, Welsh-Bohmer KA, Mayer LS, Steffens DC, Breitner JC (2002) Hormone replacement therapy and incidence of Alzheimer disease in older women: The Cache County Study. JAMA 288, 2123-2129.
34. Bagger YZ, Tanko LB, Alexandersen P, Qin G, ChristiansenC (2005) Early postmenopausal hormone therapy may prevent cognitive impairment later in life. Menopause 12, 12-17.
35. Heys M. (2010) Life course determinants of cognitive function and cardiovascular risk. Public Health PhD, University of Hong Kong.
36. Morris JC (1997) Clinical dementia rating: A reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr 9, 173-176.
37. Morris JC, Ernesto C, Schafer K, Coats M, Leon S, Sano M, Thal L, Woodbury P (1997) Clinical Dementia Rating training and reliability in multicenter studies: The Alzheimer's Disease Cooperative Study experience. Neurology 48, 1508- 1510.
38. Burke WJ, Miller JP, Rubin EH, Morris JC, Coben LA, Duchek J,Wittels IG, Berg L (1988) Reliability of theWashington University Clinical Dementia Rating. Arch Neurol 45, 31-32.
39. Rockwood K, Strang D, MacKnight C, Downer R, Morris JC (2000) Interrater reliability of the Clinical Dementia Rating in a multicenter trial. J Am Geriatr Soc 48, 558-559.
40. O'Bryant SE, Waring SC, Cullum CM, Hall J, Lacritz L, Massman PJ, Lupo PJ, Reisch JS, Doody R (2008) Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: A Texas Alzheimer's research consortium study. Arch Neurol 65, 1091-1095.
41. Reisberg B, Jamil I, Kham S, Monteiro I, Torossian C, Ferris S, Sabbagh M, Gautheir S, Auer S, Shulman M, Kluger A, Franssen E,Wegiel J. (2010) Staging dementia. In Principles and Practice of Geriatric Psychiatry, Abou-SalehMT, Katona CLE, Kumar A, eds. John Wiley & Sons, pp. 162-169.
42. Promislow JHE, Gladen BC, Sandler DP (2005) Maternal recall of breastfeeding duration by elderly women. Am J Epidemiol 161, 289-296.
43. Licastro F, Porcellini E, Caruso C, Lio D, Corder EH (2007) Genetic risk profiles for Alzheimer's disease: Integration of APOE genotype and variants that up-regulate inflammation. Neurobiol Aging 28, 1637-1643.
44. Therneau TM, Grambsch PM, Fleming TR (1990) Martingale-based residuals for survival models. Biometrika 77, 147-160.
45. Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JAE, Sherwin BB, Hsia J, Margolis KL, Hogan PE, Wallace R (2004) Conjugated equine estrogens and global cognitive function in postmenopausal women. JAMA 291, 2959-2968.
46. Karp A, Kareholt I, Qiu C, Bellander T, Winblad B, Fratiglioni L (2004) Relation of education and occupationbased socioeconomic status to incident Alzheimer's disease. Am J Epidemiol 159, 175-183.
47. Meng X, D'ArcyC(2012) Education and dementia in the context of the cognitive reserve hypothesis: A systematic review with meta-analyses and qualitative analyses. PLoS ONE 7, e38268.
48. Llewellyn-Jones D (1985) Lactation and breastfeeding. In Clinical Reproductive Endocrinology, Shearman RP, ed. Churchill Livingstone, New York.
49. NevilleMC,NeifertMR.(1983) Lactation. Physiology, Nutrition, and Breast-feeding, Plenum Press, New York.
50. Correia S, Santos R, Cardoso S, Carvalho C, Santos M, Oliveira C, Moreira P (2010) Effects of estrogen in the brain: It is a neuroprotective agent in Alzheimer's disease. Curr Aging Sci 3, 113-126.
51. Goodman Y, Bruce AJ, Cheng B, Mattson MP (1996) Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid -peptide toxicity in hippocampal neurons. J Neurochem 66, 1836- 1844.
52. Garcia-Estrada J, Del Rio J, Luquin S, Soriano E, Garcia- Segura L (1993) Gonadal hormones down-regulate reactive gliosis and astrocyte proliferation after a penetrating brain injury. Brain Res 628, 271-278.
53. Goodenough S, Schleusner D, Pietrzik C, Skutella T, Behl C (2005) Glycogen synthase kinase 3 - links neuroprotection by 17 -estradiol to key Alzheimer processes. Neuroscience 132, 581-589.
54. YaoM, Nguyen TVV, Pike CJ (2007) Estrogen regulates Bclw and Bim expression: Role in protection against -amyloid peptide-induced neuronal death. J Neurosci 27, 1422-1433.
55. Marriott L, Korol D (2003) Short-term estrogen treatment in ovariectomized rats augments hippocampal acetylcholine release during place learning. Neurobiol Learn Mem 80, 315- 322.
56. Jayaraman A, Pike CJ (2009) Progesterone attenuates oestrogen neuroprotection via downregulation of oestrogen receptor expression in cultured neurones. J Neuroendocrinol 21, 77- 81.
57. Bimonte-Nelson HA, Francis KR, Umphlet CD, Granholm ACE (2006) Progesterone reverses the spatial memory enhancements initiated by tonic and cyclic oestrogen therapy in middle-aged ovariectomized female rats. Eur J Neurosci 24, 229-242.
58. Rosario E, Ramsden M, Pike C (2006) Progestins inhibit the neuroprotective effects of estrogen in rat hippocampus. Brain Res 1099, 206-210.
59. Carroll J, Rosario E, Chang L, Stanczyk F, Oddo S, LaFerla F, Pike C (2007) Progesterone and estrogen regulate Alzheimerlike neuropathology in female 3xTg-AD mice. J Neurosci 27, 13357-13365.
60. Kuhl C (1991) Insulin secretion and insulin resistance in pregnancy andGDM.Implications for diagnosis and management. Diabetes 40, 18-24.
61. Dahlgren J (2006) Pregnancy and insulin resistance. Metab Syndr Relat Disord 4, 149-152.
62. Bell AW, Bauman DE (1997) Adaptations of glucose metabolism during pregnancy and lactation. J Mammary Gland Biol Neoplasia 2, 265-278.
63. Barbour LA, McCurdy CE, Hernandez TL, Kirwan JP, Catalano PM, Friedman JE (2007) Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care 30, S112-S119.
64. Catalano PM, Huston L, Amini SB, Kalhan SC (1999) Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 180, 903-916.
65. Naver K, Lundbye-Christensen S, Gorst-Rasmussen A, Nilas L, Secher N, Rasmussen S, Ovesen P (2011) Parity and risk of diabetes in a Danish nationwide birth cohort. Diabet Med 28, 43-47.
66. Kjos SL, Henry O, Lee RM, Buchanan TA, Mishell Jr DR (1993) The effect of lactation on glucose and lipid metabolism inwomen with recent gestational diabetes. Obstet Gynecol 82, 451-455.
67. Stuebe AM, Rich-Edwards JW, Willett WC, Manson JAE, Michels KB (2005) Duration of lactation and incidence of type 2 diabetes. JAMA 294, 2601-2610.
68. Taylor JS, Nothnagle M, Magee SR (2010) Chapter 22: Breastfeeding and diabetes: Pathophysiology and therapy. In Diabetes inWomen, Tsatsoulis A,Wyckoff J, Brown FM, eds. Humana Press, New York, pp. 415-433.
69. Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ, Wands JR, Monte SM (2005) Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes J Alzheimers Dis 7, 63-80.
70. Haan MN (2006) Therapy Insight: Type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease. Nat Clin Pract Neurol 2, 159-166.
71. PedersenWA,McMillan PJ, Kulstad JJ, Leverenz JB, Craft S, Haynatzki GR (2006) Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice. Exp Neurol 199, 265-273.
72. Reger M, Watson G, Frey Ii W, Baker L, Cholerton B, Keeling M, Belongia D, Fishel M, Plymate S, Schellenberg G (2006) Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype. Neurobiol Aging 27, 451-458.
73. Reger M, Watson G, Green P, Wilkinson C, Baker L, Cholerton B, Fishel M, Plymate S, Breitner J, DeGroodt W (2008) Intranasal insulin improves cognition and modulates -amyloid in early AD. Neurology 70, 440-448.
74. DeBellis A, Bizzarro A, BellastellaA(2008) Role of prolactin in autoimmune diseases. Handb Systemic Autoimmune Dis 9, 29-43.
75. Yu-Lee LY (2002) Prolactin modulation of immune and inflammatory responses. Recent Prog Horm Res 57, 435-455.
76. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA (1998) Prolactin (PRL) and its receptor: Actions, signal transduction pathways, and phenotypes observed inPRLreceptor knockout mice. Endocr Rev 19, 225-268.
77. Jara LJ, Medina G, Saavedra MA, Vera-Lastra O, Navarro C (2011) Prolactin and autoimmunity. Clin Rev Allergy Immunol 40, 50-59.
78. Horseman ND, ZhaoW, Montecino-Rodriguez E, Tanaka M, Nakashima K, Engle SJ, Smith F, Markoff E, Dorshkind K (1997) Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene.EMBO J 16, 6926-6935.
79. Bouchard B, Ormandy C, Di Santo J, Kelly P (1999) Immune system development and function in prolactin receptordeficient mice. J Immunol 163, 576-582.
80. Murphy WJ, Durum S, Longo DL (1993) Differential effects of growth hormone and prolactin on murine T cell development and function. J Exp Med 178, 231-236.
81. Cooper GS, Dooley MA, Treadwell EL, St. Clair EW, Gilkeson GS (2002) Hormonal and reproductive risk factors for development of systemic lupus erythematosus: Results of a population-based, case-control study. Arthritis Rheum 46, 1830-1839.